Amended in Assembly May 24, 2013

Amended in Assembly May 7, 2013

Amended in Assembly March 19, 2013

California Legislature—2013–14 Regular Session

Assembly BillNo. 686


Introduced by Assembly Member Quirk

February 21, 2013


An act to add and repeal Section 25201.18 of the Health and Safety Code, relating to hazardous waste.

LEGISLATIVE COUNSEL’S DIGEST

AB 686, as amended, Quirk. Hazardous waste: pharmaceutical facilities.

Existing law requires hazardous waste facilities, including, but not limited to, treatment facilities, to operate under hazardous waste facilities permits or other grants of authorization issued by the Department of Toxic Substances Control. Existing law exempts pharmaceutical neutralization activities from certain requirements of the hazardous waste control laws and certain regulations adopted pursuant to that law if specified conditions are met with regard to the pharmaceutical manufacturing or process development activities, including the management of air emissions and wastes generated as a result of those activities.

This bill would require the department, by January 1,begin delete 2015end deletebegin insert 2016end insert, to develop recommendations for standards and guidelines for the operation of onsite waste management and recycling of hazardous waste at facilities engaged in pharmaceutical manufacturing or pharmaceutical process development. The department would be required, by January 1,begin delete 2015end deletebegin insert 2016end insert, to submit a report to the Legislature on those recommendations, including any recommended statutory and regulatory actions needed to assure the safe and efficient management of waste from pharmaceutical manufacturing or pharmaceutical process developmentbegin delete activesend deletebegin insert activitiesend insert. The bill would repeal this report requirement on January 1, 2019.

Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: no.

The people of the State of California do enact as follows:

P2    1

SECTION 1.  

Section 25201.18 is added to the Health and
2Safety Code
, to read:

3

25201.18.  

(a) On or before January 1,begin delete 2015end deletebegin insert 2016end insert, the
4department shall develop recommendations for standards and
5guidelines for the operation of onsite hazardous waste management
6and recycling activities at facilities engaged in pharmaceutical
7manufacturing or pharmaceutical process development. The
8recommendations shall consider, but are not limited to, all of the
9following:

10(1) Actions to reduce the production and offsite disposal of
11hazardous waste from pharmaceutical manufacturing operations.

12(2) Actions to provide incentives to reduce greenhouse gas
13emissions through increased energy efficiency.

14(3) Recommended permit conditions or other requirements for
15onsite waste management within a pharmaceutical manufacturing
16facility to ensure the protection of public health and the
17environment and that recognize the unique federal and state
18requirements that apply to pharmaceutical manufacturing.

19(b) On or before January 1,begin delete 2015end deletebegin insert 2016end insert, the department shall
20submit a report to the Legislature in compliance with Section 9795
21of the Government Code on the recommendations developed
22pursuant to subdivision (a), including any recommended statutory
23and regulatory actions needed to assure the safe and efficient
24management of hazardous waste from pharmaceutical
25manufacturing or pharmaceutical process development activities.

26(c) This section shall remain in effect only until January 1, 2019,
27pursuant to Section 10231.5 of the Government Code and as of
P3    1that date is repealed, unless a later enacted statute, that is enacted
2before January 1, 2019, deletes or extends that date.



O

    96